Electroencephalography (EEG) can help narrow the differential diagnosis of altered mental status (AMS) and is necessary to diagnose nonconvulsive seizure (NCS). The objective of this prospective observational study is to identify the prevalence of EEG abnormalities in emergency department patients with AMS. Patients of at least 13 years of age with AMS were enrolled, whereas those with an easily identifiable cause (e.g. hypoglycemia) underlying their AMS were excluded. Easily identifiable cause of AMS (e.g. hypoglycemia). A 30-min EEG with the standard 19 electrodes was performed on each patient. Descriptive statistics (%, 95% confidence interval) are used to report EEG findings of the first 50 enrolled patients. Thirty-five EEGs (70%, 57-81%) were abnormal. The most common abnormality was slowing of background activities (46%, 33-60%), reflecting an underlying encephalopathy. NCS was diagnosed in three (6%, 1-17%), including one patient in nonconvulsive status epilepticus. Nine patients (18%, 10-31%) had interictal epileptiform abnormalities, indicating an increased risk of spontaneous seizure. Patients presenting to the emergency department with AMS have a high prevalence of EEG abnormalities, including NCS.
Introduction
Two to ten percent of the 120 million patients evaluated annually in US emergency departments (EDs) present with altered mental status (AMS), with the most common underlying etiology being neurological disease [1, 2] . Electroencephalography (EEG) findings can often help narrow the differential diagnosis and may also provide valuable prognostic information [3, 4] . Unfortunately, EEG is not routinely available in EDs, and is therefore rarely part of the acute evaluation of patients with AMS. The absence of the EEG data may delay establishment of the correct diagnosis and may lead to unnecessary tests, procedures, admissions, and costs.
Methods
The main aims of this prospective observational study are to determine the prevalence and type of EEG abnormalities and to evaluate a novel, miniature, wireless EEG technology in ED patients of at least 13 years of age with AMS. Enrolled patients undergo an EEG with the experimental device and a separate EEG with a standard, commercially available EEG machine. Here, we report data on EEGs obtained using the standard system (the experimental EEG system is investigational and has not yet been approved for marketing by the FDA). The study was approved by the institutional review board, which waived the requirement for informed consent.
The study is being performed in the EDs of two urban academic hospitals in New York with approximately 205 000 ED visits per year combined. These hospitals provide care to an underserved population in a primarily Caribbean-American and African-American community. All patients of at least 13 years of age presenting with AMS of any severity are screened for enrollment on a 24/7 basis. Patients whose AMS is because of a rapidly correctable etiology such as hypoglycemia, hypotension, hypothermia, hyperthermia, or narcotic overdose are excluded, as are those with severe facial or scalp injuries. Each enrolled patient undergoes a standard 30 min EEG obtained with a full set of 19 goldplated cup electrodes applied according to the international 10-20 system, with all electrode impedances of 5 kO or less. Patient demographics, presenting symptoms, and other relevant clinical data are also collected. The standard EEG is screened remotely 24/7 by an on-call clinical neurophysiologist, who reports the findings to the ED attending physician.
Outcome measures
Specific EEG findings.
Statistical analysis
The results are presented with descriptive statistics. Continuous variables are described as mean±SD and frequencies are reported as percentages with 95% confidence intervals (CI).
Results
The study population included 24 men (48%) and 26 women (52%), mean age 60±20 years (range, 13-92). The EEG findings are shown in detail in Table 1 . Most importantly, 35 (70%, 95% CI, 57-81%) of the EEGs were abnormal. Twenty-three (46%, 95% CI, 33-60%) showed slowing of background activities (without additional abnormalities), three studies (6%, 95% CI, 1-17%) showed nonconvulsive seizure (NCS), with one of these showing nonconvulsive status epilepticus (NCSE) (Fig. 1 ), and nine (18%, 95% CI, 9.5-31%) had epileptiform discharges (i.e. sharp waves, spikes, or spike-wave discharges). These interictal epileptiform discharges are not seizure activity, but they reflect cortical irritability and indicate an increased risk of spontaneous seizure. Eight EEGs were normal (16%, 95% CI, 8-29%) and seven (14%, 95% CI, 7-27%) were considered uninterpretable for technical or other reasons.
The ED disposition diagnoses (clinical impression at the time of disposition) for patients in each EEG category are also presented in Table 1 .
Discussion
AMS is a common presenting symptom of ED patients. The differential diagnosis of AMS is broad, even after eliminating easily determined and treatable causes such as hypotension, hypoglycemia, etc. EEG can help to narrow the differential diagnosis, for example by ruling out a physiologic encephalopathy on the basis of the presence or absence of pathologic slowing of EEG waveforms. Some diagnoses, such as NCS or severe hepatic encephalopathy, cannot be made without EEG. Despite its clinical utility, EEG is simply not available on an urgent or an emergent basis in most EDs. An informal Internet-based survey (unpublished data) performed by the authors found that only 2% of EDs are equipped with EEG machines or have a technologist who can properly apply EEG electrodes, troubleshoot problems, and record a technically adequate study. Thus, ED physicians may not be aware of its value or the prevalence of abnormal EEG findings in AMS patients. The paucity of institutions equipped to perform urgent EEG in the ED on a 24/7 basis has also impeded previous studies of EEG in the ED setting.
In this report, we show that EEG abnormalities are very common in a consecutive sample of 50 patients of at least 13 years of age presenting with AMS of uncertain etiology. As expected, the most common EEG abnormality was slowing, a finding indicative of encephalopathy, but nonspecific as to the cause. The presence of diffuse slowing, particularly if it is of at least moderate severity, would rule out a purely psychogenic or psychiatric etiology of the AMS, and thus aids in narrowing the differential diagnosis. In fact, Firosh Khan et al. [5] showed that EEG performed emergently in the context of encephalopathy had a major impact on management and prognosis, especially when other specific biochemical and microbiological investigations were unavailable.
Three of the 50 patients had NCS during the EEG, including one in NCSE. This crucial finding, which cannot be diagnosed without an EEG, impacts acute patient management and may obviate the need for additional diagnostic studies. The prevalence of NCS in this cohort is similar to that reported in the only other study that enrolled consecutive ED patients with AMS [6] . Other studies performed in the ED, ICU, and/or hospital ward have reported higher rates of NCS, but in each case, the pretest probability of NCS was elevated, that is the EEG was requested because of a clinical suspicion of NCS [7] . Some cases of NCS in our population may have been missed, as a seizure may not have occurred during the 30-min EEG. Detection of NCS increases with repeated or prolonged EEG monitoring [8, 9] .
The epileptiform discharges observed in nine of the recordings indicate an increased risk of the occurrence of a spontaneous seizure. They are an interictal finding most commonly seen in patients with epilepsy, but may also occur with an acute or a subacute structural brain injury, or in specific toxic-metabolic encephalopathies such as lithium overdose [10] .
Although a normal EEG does not exclude all serious cerebral pathologies, it does exclude NCSE, toxicmetabolic encephalopathy, and acute or subacute lesions (tumor, abscess, stroke, etc.) large enough to produce focal slowing of EEG activity.
Seven EEGs were technically limited because of excessive artifact. This is not unexpected in the ED environment, where EEG signals often contain abundant 60 Hz noise because of the high ambient electrical noise level. Also, patients with AMS may accidentally or deliberately remove electrodes during the study because of their confusion, agitation, or frank combativeness. In studies of EEG in ED patients with AMS, a 10-15% rate of uninterpretable recordings is typical. In this study, EEG readers used a very liberal definition of 'uninterpretable', such that many EEGs with considerable artifact-free portions were still classified as uninterpretable.
Limitations
This report presents the results from the first 50 patients in a study that is expected to enroll 260 participants. The final distribution of EEG abnormalities may differ from those presented here, although there is no reason to suspect that the overall prevalence of abnormal findings will change substantially. The EEG findings reported here are those of the individual clinical neurophysiologists who interpreted each study and were not subjected to an analysis of inter-rater reliability. However, all of the interpreters completed clinical EEG/epilepsy fellowships and are board-certified in clinical neurophysiology. As mentioned previously, some cases of NCS may have been missed if a seizure did not occur during the EEG. This limitation is an unavoidable consequence of the limited duration of both seizures and EEGs.
Conclusion
ED patients of at least 13 years of age presenting with AMS have a very high rate of EEG abnormalities. The most common abnormality is slowing of background activities (diffuse or focal), consistent with an underlying encephalopathy. Some patients have clinically unapparent NCS or are in frank NCSE, diagnoses that can be made only by EEG and that trigger specific treatment protocols.
These data support the value of incorporating EEG into the initial evaluation of patients presenting with AMS to the ED.
